News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Visijet Inc. Files For FDA Approval Of Epi-Tome; Product Currently Being Sold In Europe And Korea; Addresses $4 Billion Refractive Surgery Market



10/19/2005 5:11:42 PM

VisiJet Inc. (OTCBB:VJET), developers of innovative technologies for the ophthalmic surgical market, announced today that a 510K filing has been made with the FDA for approval of the Epi-Tome(TM), a next-generation, ophthalmic surgical tool designed for cutting and separating corneal tissue. The company recently acquired worldwide distribution rights for the product from Gebauer Medizintechnik GmbH of Neuhausen, Germany.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES